Schematherapie (Gitta Jacob)

Marsoni

M251S

$14.45

Get it in 3 business days with 1 day shipping. Friday, May 29

Schematherapie (Gitta Jacob)Die Schematherapie ist eine wichtige Weiterentwicklung der kognitiven Verhaltenstherapie (KVT) fr Patientinnen und Patienten mit Persnlichkeitsstrungen und anderen chronischen psychischen Problemen. In Studien hat sich insbesondere die Arbeit mit dem Schemamodus Ansatz als hoch wirksam erwiesen. In der aktualisierten Auflage des Bandes, die insbesondere auch aktuelle Befunde zur Evidenz referiert, wird die Behandlung mit dem Modusmodell praxisnah

Easy Shipping

Quick Dispatch:

Your Schematherapie (Gitta Jacob) orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Schematherapie (Gitta Jacob) ships.

Need Help?
Questions about Schematherapie (Gitta Jacob), sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Schematherapie (Gitta Jacob) in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Great product, sturdy design and easy to build! It is a fairly light weight item, which aids in the maneuverability of the divider. The color was as described and is dark enough to block the light from our sleeping infants! I do love that you are able to see through the slats and see the child sleeping- if you are looking for something with MORE privacy, this is not it. It has great coverage area and is dark and a wonderful value for the price, however, you are able to see through the areas where each panel connects!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on August 18, 2025